1. Home
  2. GHG vs GOSS Comparison

GHG vs GOSS Comparison

Compare GHG & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

HOLD

Current Price

$1.87

Market Cap

205.1M

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$3.19

Market Cap

796.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GHG
GOSS
Founded
2004
2015
Country
China
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.1M
796.2M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
GHG
GOSS
Price
$1.87
$3.19
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.60
AVG Volume (30 Days)
22.8K
4.2M
Earning Date
12-23-2025
11-05-2025
Dividend Yield
5.49%
N/A
EPS Growth
N/A
N/A
EPS
0.25
N/A
Revenue
$166,761,937.00
$44,051,000.00
Revenue This Year
$19.02
N/A
Revenue Next Year
$8.26
$6.41
P/E Ratio
$7.28
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.66
$0.76
52 Week High
$3.25
$3.87

Technical Indicators

Market Signals
Indicator
GHG
GOSS
Relative Strength Index (RSI) 47.57 46.76
Support Level $1.66 $3.21
Resistance Level $1.99 $3.87
Average True Range (ATR) 0.09 0.29
MACD 0.01 -0.06
Stochastic Oscillator 40.91 3.42

Price Performance

Historical Comparison
GHG
GOSS

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: